Clinical trial
LMBA02 Protocol for Patients With a Burkitt Lymphoma
NCT00180882 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LMBA02 Protocol for Patients With a Burkitt Lymphoma
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 31, 2004
- Completion date
- Not reported
- Enrollment
- 260
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.